The PaldiSpot test detects the presence of Borrelia, Babesia and Bartonella genospecies in a DNA sample.
Used in combination with our PrimeSpot test, the PaldiSpot test provides critical information for patients with Lyme Disease and chronic fatigue syndrome. The results can help your clinician develop effective personalised treatment and therapies.
The PaldiSpot test is clinically validated and highly accurate. It is suitable for adults aged 18 and over. Results are processed and returned to your clinician within 14 days.
The PaldiSpot test analyses DNA extracted from your blood cells and serum to screen for the most common strains of Borrelia, Babesia and Bartonella.
Working from our world-class facilities in Europe, our scientists use a highly sensitive molecular biology technique called quantitative polymerase chain reaction (qPCR) to analyse DNA extracted from your blood sample to screen for the presence 23 of the most common strains of Borrelia, Babesia and Bartonella genospecies.
The PaldiSpot test provides your clinician with information on the specific genospecies present in your DNA and its threshold.
The PaldiSpot genetic test can only be ordered through your clinician.
Please download this letter and take it along to your next appointment. Results are processed and returned to your clinician within 14 days.
Determine your risk of developing non-cancerous diseases.Learn more
Accurately diagnose Lyme Disease and chronic fatigue syndrome.Learn more
Accurate screenings to help determine your response to treatment.Learn more
Reliable tests to identify your particular strain of Lyme disease.Learn more